Search results
AbbVie stock gains as Rinvoq succeeds in giant cell arteritis
Seeking Alpha· 6 days agoAbbVie (ABBV) stock gains as the company's JAK inhibitor, upadacitinib, succeeds in a Phase 3 trial...
Alvotech and Teva’s Selarsdi™ (ustekinumab-aekn), Biosimilar to Stelara® Approved by FDA | JD Supra
JD Supra· 17 hours agoAccording to an April 2024 press release, Alvotech and Teva’s Selarsdi™ (ustekinumab-aekn) was approved by the FDA on April 16 as a biosimilar of Janssen / Johnson & Johnson’s Stelara® (ustekinumab ...
AbbVie Inc. (NYSE:ABBV) to Post Q1 2024 Earnings of $2.21 Per Share, William Blair Forecasts
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at William Blair issued their Q1 2024 EPS estimates for AbbVie in a research note issued to investors on Wednesday, April 17th. William ...
Biogen Inc. (NASDAQ:BIIB) to Post Q3 2024 Earnings of $4.13 Per Share, Wedbush Forecasts
ETF DAILY NEWS· 5 days agoBiogen Inc. (NASDAQ:BIIB – Free Report) – Investment analysts at Wedbush raised their Q3 2024 earnings estimates for Biogen in a research note issued to investors on Wednesday, April 17th. Wedbush ...
AbbVie (NYSE:ABBV) Shares Up 1.8%
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 1.8% on Thursday . The company traded as high as $167.44 and last traded at $167.14. BMO Capital Markets raised their price target on shares ...
FY2025 EPS Estimates for AbbVie Inc. (NYSE:ABBV) Lowered by Analyst
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Free Report) – Investment analysts at William Blair dropped their FY2025 EPS estimates for shares of AbbVie in a report released on Wednesday, April 17th. William Blair ...
Greenleaf Trust Increases Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 2 days agoGreenleaf Trust increased its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 20.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission ...
Sumitomo Mitsui DS Asset Management Company Ltd Has $4.59 Million Stock Position in Biogen Inc....
ETF DAILY NEWS· 2 days agoSumitomo Mitsui DS Asset Management Company Ltd lessened its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.4% during the 4th quarter, according to the company in its most ...
William Blair Comments on Biogen Inc.’s Q1 2024 Earnings (NASDAQ:BIIB)
ETF DAILY NEWS· 4 days agoBiogen Inc. (NASDAQ:BIIB – Free Report) – Investment analysts at William Blair cut their Q1 2024 earnings estimates for shares of Biogen in a report issued on Wednesday, April 17th. William ...
Biogen (NASDAQ:BIIB) Price Target Cut to $214.00
ETF DAILY NEWS· 6 days agoBiogen (NASDAQ:BIIB – Get Free Report) had its price target reduced by equities research analysts at UBS Group from $250.00 to $214.00 in a research note issued on Wednesday, Benzinga reports ...
